AbbVie Inc.
ABBV
$210.75
-$0.79-0.37%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.00M | 1.56B | 1.37B | 1.37B | 822.00M |
| Total Depreciation and Amortization | 2.10B | 2.08B | 2.13B | 2.07B | 2.08B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.37B | 1.06B | 2.15B | 350.00M | 1.41B |
| Change in Net Operating Assets | -397.00M | 750.00M | -3.38B | 247.00M | 443.00M |
| Cash from Operations | 7.05B | 5.45B | 2.27B | 4.04B | 4.75B |
| Capital Expenditure | -291.00M | -249.00M | -241.00M | -193.00M | -205.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.79B | -8.49B | -843.00M | -9.39B | -553.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 209.00M | 486.00M | -18.00M | -6.00M | -42.00M |
| Cash from Investing | -1.87B | -8.26B | -1.10B | -9.59B | -800.00M |
| Total Debt Issued | 2.00B | 0.00 | 0.00 | 19.97B | -- |
| Total Debt Repaid | -5.76B | -403.00M | -3.35B | -5.11B | -1.79B |
| Issuance of Common Stock | 10.00M | 67.00M | 10.00M | 127.00M | 31.00M |
| Repurchase of Common Stock | -358.00M | -17.00M | -9.00M | -1.32B | -3.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.75B | -2.75B | -2.75B | -2.77B | -2.63B |
| Other Financing Activities | 1.00M | 32.00M | 0.00 | -75.00M | -57.00M |
| Cash from Financing | -6.86B | -3.07B | -6.10B | 10.82B | -4.45B |
| Foreign Exchange rate Adjustments | -46.00M | 8.00M | -9.00M | -18.00M | 23.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.73B | -5.87B | -4.94B | 5.25B | -473.00M |
